We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Gazyva
Australian Public Assessment Report
Device/Product Name
Gazyva
Active ingredients
Obinutuzumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-03031-1-6
Submission Type
Extension of indication
Decision
Approved